merck oral glp-1 Aleniglipron: An Oral, Small Molecule GLP-1R Agonist Fast-Follower from Structure Therapeutics Oral Treatment of Obesity by

Factors such as the accumulation of lipid metabolites, inflammatory processes, and dysfunction in hypothalamic neurons may also contribute to obesity, potentially explaining the biological mechanisms that favor the maintenance of excessive body fat [7]

Noh JW, Jun MS, Yang HK, Lee BC

Practical protein strategies when appetite is suppressed Protein-first eating

GLP-1 receptor agonists are a class of prescription medications proven to support significant weight loss

Multiple other causes should be considered including peripheral vascular disease, neuropathy, medication effects from other drugs (particularly diuretics, beta-agonists, and statins), hypothyroidism, pregnancy, and musculoskeletal conditions

When patients use these medications, they have a physiologic benefit of lower appetite, increase satiety and improvement in fat cell metabolism as well as improvements in insulin resistance, says Dr